HIGH-DOSE ORAL MEDROXYPROGESTERONE ACETATE IN ADVANCED BREAST-CANCER

被引：0
作者：
HEDLEY, D [1 ]
DALGLEISH, A [1 ]
COATES, A [1 ]
FOX, R [1 ]
RAGHAVAN, D [1 ]
TATTERSALL, M [1 ]
机构：
[1] LUDWIG INST CANC RES,SYDNEY CANC THERAPY BRANCH,SYDNEY,AUSTRALIA
来源：
MEDICAL AND PEDIATRIC ONCOLOGY | 1983年 / 11卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：205 / 205
页数：1
相关论文
共 50 条
[21]   HIGH-DOSE VERSUS LOW-DOSE MEDROXYPROGESTERONE ACETATE - A RANDOMIZED TRIAL IN ADVANCED BREAST-CANCER [J].
GALLAGHER, CJ ;
CAIRNDUFF, F ;
SMITH, IE .
EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1987, 23 (12) :1895-1900
[22]   THE PHARMACOKINETICS OF HIGH-DOSE MEDROXYPROGESTERONE ACETATE IN THE THERAPY OF METASTATIC BREAST-CANCER [J].
BLOSSEY, HC ;
BARTSCH, HH ;
KOEBBERLING, J ;
NAGEL, GA .
ACTA ENDOCRINOLOGICA, 1981, 97 :207-207
[23]   STEROID-HORMONE RECEPTORS AND RESPONSE TO HIGH-DOSE MEDROXYPROGESTERONE ACETATE IN ADVANCED BREAST-CANCER [J].
NOMURA, Y ;
TASHIRO, H ;
HISAMATSU, K ;
SHINOZUKA, K .
ANTICANCER RESEARCH, 1988, 8 (04) :647-652
[24]   ORAL HIGH-DOSE MEDROXYPROGESTERONE ACETATE VERSUS TAMOXIFEN - A RANDOMIZED CROSSOVER TRIAL IN POSTMENOPAUSAL PATIENTS WITH ADVANCED BREAST-CANCER [J].
VANVEELEN, H ;
WILLEMSE, PHB ;
TJABBES, T ;
SCHWEITZER, MJH ;
SLEIJFER, DT .
CANCER, 1986, 58 (01) :7-13
[25]   A PHASE-III TRIAL OF ORAL HIGH-DOSE MEDROXYPROGESTERONE ACETATE (MPA) VERSUS MEPITIOSTANE IN ADVANCED POSTMENOPAUSAL BREAST-CANCER [J].
IZUO, M ;
YOSHIDA, M ;
TOMINAGA, T ;
ABE, O ;
ENOMOTO, K ;
NOMURA, Y ;
KUBO, K ;
TAKATANI, O .
CANCER, 1985, 56 (11) :2576-2579
[26]   5-FLUOROURACIL, ADRIAMYCIN AND CYCLOPHOSPHAMIDE COMBINED WITH HIGH-DOSE MEDROXYPROGESTERONE ACETATE IN ADVANCED BREAST-CANCER [J].
LOPEZ, M ;
DILAURO, L ;
PERNO, CF ;
PAPALDO, P ;
BARDUAGNI, M ;
BARDUAGNI, A .
TUMORI, 1983, 69 (06) :545-551
[27]   MECHANISM OF ADRENAL SUPPRESSION BY HIGH-DOSE MEDROXYPROGESTERONE ACETATE IN BREAST-CANCER PATIENTS [J].
VANVEELEN, H ;
WILLEMSE, PHB ;
SLEIJFER, DT ;
VANDERPLOEG, E ;
SLUITER, WJ ;
DOORENBOS, H .
CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1985, 15 (02) :167-170
[28]   CHEMOTHERAPY WITH OR WITHOUT HIGH-DOSE MEDROXYPROGESTERONE ACETATE IN ESTROGEN-RECEPTOR-NEGATIVE ADVANCED BREAST-CANCER [J].
GUNDERSEN, S ;
KVINNSLAND, S ;
KLEPP, O ;
LUND, E ;
HANNISDAL, E ;
HOST, H .
EUROPEAN JOURNAL OF CANCER, 1992, 28A (2-3) :390-394
[29]   HIGH-DOSE MEDROXYPROGESTERONE ACETATE PLUS MITOMYCIN-C OR VINDESINE IN THE TREATMENT OF ADVANCED BREAST-CANCER [J].
FALKSON, CI ;
FALKSON, HC ;
FALKSON, G .
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1988, 11 (04) :431-434
[30]   HIGH-DOSE MEDROXYPROGESTERONE ACETATE IN BREAST-CANCER RESISTANT TO ENDOCRINE AND CYTOTOXIC THERAPY [J].
DELENA, M ;
BRAMBILLA, C ;
VALAGUSSA, P ;
BONADONNA, G .
CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1979, 2 (03) :175-180
12345